Recruitment

Recruitment Status
Completed
Estimated Enrollment
70

Inclusion Criterias

Best corrected visual acuity of approximately 20/400 to 20/40 in the study eye
Diagnosis of macular edema
Best corrected visual acuity of approximately 20/400 to 20/40 in the study eye
Diagnosis of macular edema

Exclusion Criterias

Use of systemic steroids (eg, oral, intravenous, intramuscular, epidural, rectal, or extensive dermal) within 1 month
Intraocular surgery, including cataract surgery, and/or laser surgery of any type within 3 months
Any active ocular infection in either eye
Use of systemic steroids (eg, oral, intravenous, intramuscular, epidural, rectal, or extensive dermal) within 1 month
Intraocular surgery, including cataract surgery, and/or laser surgery of any type within 3 months
Any active ocular infection in either eye

Summary

Conditions
  • Macular Edema
  • Retinal Vein Occlusion
Type
Interventional
Phase
Phase 4
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criterias

Best corrected visual acuity of approximately 20/400 to 20/40 in the study eye
Diagnosis of macular edema
Best corrected visual acuity of approximately 20/400 to 20/40 in the study eye
Diagnosis of macular edema

Exclusion Criterias

Use of systemic steroids (eg, oral, intravenous, intramuscular, epidural, rectal, or extensive dermal) within 1 month
Intraocular surgery, including cataract surgery, and/or laser surgery of any type within 3 months
Any active ocular infection in either eye
Use of systemic steroids (eg, oral, intravenous, intramuscular, epidural, rectal, or extensive dermal) within 1 month
Intraocular surgery, including cataract surgery, and/or laser surgery of any type within 3 months
Any active ocular infection in either eye

Locations

Seoul
Seoul

Tracking Information

NCT #
NCT01903720
Collaborators
Not Provided
Investigators
Study Director: Medical Director Allergan